Administration of Systemic Propolis Versus Moxifloxacin as Adjunctive Treatment of Severe Generalized Periodontitis

Anees, Mohamed M.; Abo-Shady, Tamer Elamer; El-Sharkawy, Hesham

doi:10.21608/edj.2019.72202

Cited by 1 publication

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Also in a study of Anees et al, 44 they compared the effect of systemic administration of 400 mg capsule propolis and moxifloxacin 400 mg daily for 7 days as an adjunct to SRP. They concluded that both propolis and moxifloxacin significantly improve the PD, CAL, bleeding on probing and gingival index as well as significantly decrease the salivary level of IL-1β compared to SRP alone.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of adjunctive effect of daily dietary supplements with omega 3 and propolis to non-surgical periodontal therapy: Randomized Clinical Trial

Shalaby

Morsy

2019

Egyptian Dental Journal

View full text Add to dashboard Cite

Background and Objective:This study aimed to investigate the systemic effect of dietary supplement omega 3 (ω-3) polyunsaturated fatty acids (PUFAs ) and propolis as an adjunct to non surgical periodontal therapy and evaluate the gingival crevicular fluid level of receptor activator of nuclear factor κ ligand (RANKL). Material and Methods:Forty-five subjects with stage II or III and grade B periodontitis were included in this study. They were randomly assigned into three groups: Group I: 15 subjects received scaling and root planing (SRP) only. Group II: 15 subjects received SRP combined with daily dietary supplementation of omega 3 for 6 months. Group III: 15 subjects received SRP combined with a daily dietary supplement of propolis for 6 months. Clinical parameter (plaque index, bleeding index, pocket depth, and clinical attachment level) and biochemical analysis of RANKL in GCF were recorded at baseline, 3 months and 6 months after treatments Results: Statistical analysis revealed that both (ω-3) and propolis statistically significant (P≤0.01) reduce PD and CAL at 3 and 6 months compared to its baseline and control group. RANKL level in GCF statistically significant (P≤0.01) reduced at 3 and 6 months in both treated groups compared to its baseline and control group. No statistical significant (P≥0.05) difference between both treated groups concerning clinical and biochemical parameters.Conclusion: The present study suggests that dietary supplementation with ω-3 PUFAs or propolis effective as an adjunct to nonsurgical periodontal therapy in the management of patients with periodontitis.

show abstract

Section: Discussionmentioning

confidence: 99%